The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Investors were in a sell-the-news mood this week. Just the whiff of bad news sent many stocks sharply lower. And, as you’ll see, the MarketBeat analysts were quick to dissect the news and how it ...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost ...

In today's Black History Month spotlight, Wealth host Brad Smith highlights Taco Bell CEO Sean Tresvant, who assumed ...

Nutrafol’s latest product ushers the brand into new (hair care) territory. And it’s a terrific option for guys with short ...